Protein Post-Translational Modifications in the Regulation of Ferroptosis: New Opportunities and Challenges for Cancer Immunotherapy
Xin Xie, Lizhou Song, Zhaoyu Li, Jiahao Hu, Zhiheng Lin, Yadong Guo, Haoling Zhang, Wangzheqi Zhang, Zui Zou · 2026
Read Protein Post-Translational Modifications in the Regulation of Ferroptosis: New Opportunities and Challenges for Cancer Immunotherapy by Xin Xie, Lizhou Song, Zhaoyu Li, Jiahao Hu, Zhiheng Lin, Yadong Guo, Haoling Zhang, Wangzheqi Zhang, Zui Zou (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13618227.txt.
Description
Xin Xie and co-authors review protein modifications controlling iron-driven cell death in cancer in a 2026 paper. This death mode, ferroptosis, runs on iron and lipid damage. It suppresses tumor growth when triggered properly. Proteins get chemically edited after production, changing their behavior.
The review maps how common edits steer key death regulators. Four modification types receive detailed treatment. Each can stabilize, relocate, or switch proteins on and off. The death pathway also talks with tumor immunity. Dying cells release signals that reshape their surroundings. Those signals can wake immune attack on the tumor. Checkpoint drug response may improve when death is induced. T cell and natural killer activity feature in the plans. The authors weigh chances against hard challenges honestly. Combination strategies based on modifications close the outlook. Translation to clinic remains the field's bottleneck.
Catalog record
| CREATOR | Xin Xie, Lizhou Song, Zhaoyu Li, Jiahao Hu, Zhiheng Lin, Yadong Guo, Haoling Zhang, Wangzheqi Zhang, Zui Zou |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 173 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |